藥物成份

共有 20749 個藥物成份

• SHBG Cal1: 2×1mL\n• SHBG Cal2: 2×1mL\nThe concentration of SHBG Cal1 is approx. 0 nmol/L; SHBG Cal2 contains approx. 40 nmol/L human SHBG in a human serum matrix.

• 關聯藥證數量: 1

( 1 test strip contains as below)1. Blood: Tetramethylbenzidine 12μg, Cumene hydroperoxide 5μL\n2. Bilirubin: Sodium nitrite 13μg, Substituted aniline diazonium salt q.s.\n3. Urobilinogen: 4-Diethylaminobenzaldehyde 26μg\n4. Ketone: Sodium nitroprusside 0.19 mg\n5. Protein: Terabromophenol blue 2μg\n6. Nitrite: p-arsanilic acid 56μg, 1,2,3,4-tetrahydrobenzoquinolin-3-ol 10μg\n7. Glucose: Glucose oxidase 1.1 unit, Peroxidase 0.13 unit, Potassium Iodide 0.3 mg \n8. pH: Methyl red 1.3μg, Bromothymol blue 9μg\n9. Specific Gravity: Bromothymol blue 18μg\n10. Leucocyte: Derivatized phenylpyrrole 9μg, Diazonium salt 7μg\n11. Ascorbic acid: 2, 6-Dichlorophenol Indophenol 0.75 mg

• 關聯藥證數量: 1

(+)-Pseudoephedrine Sulfate 80/200 contains not less than 98.5% and not more than 100.5% of (C10H15NO)2？H2SO4, calculated with reference to the dried substance.

• 關聯藥證數量: 1

(-)Phenylephrine Hydrochloride contains not less than 97.5 percent and not more than 102.5 percent of C9H13NO2‧HCl, calculated on the dried basis.

• 關聯藥證數量: 1

(1) 23.67 % w/w glucose oxidase (25 U/strip, from Aspergillus Niger)\n(2) 37.41% w/w potassium ferricyanide\n(3) 38.93% w/w non-reactive ingredients\n

• 關聯藥證數量: 1

(1) ADVIA Centaur CA 19-9A: lite reagent, solid phase\n(2) ACS: 180 CA 19-9: lite reagent, solid phase\nlite reagent: monoclonal mouse anti-CA 19-9 antibody (~ 1.5 ug/vial) labeled with acridinium ester in buffer with protein stabilizers, sodium azide, (0.1%), and preservatives.\nsolid phase: monoclonal mouse anti-CA 19-9 antibody (~ 0.54 mg/vial)\ncovalently coupled to paramagnetic particles in buffer with protein stabilizers, sodium azide, (0.1%), and preservtives.\n(3) Calibrator 9: After reconstitution, low or high levels of CA 19-9 in fetal bovine serum with sodium azide (<0.1%) and preservatives.\n

• 關聯藥證數量: 1

(1) ADVIA Centaur CKMB: lite reagent, solid phase lite reagent：monoclonal mouse anti-CK-MB antibody(~0.11 ug/mL) labeled with acridinium ester in buffer with sodium azide (0.11%), protein stabilizers, and preservatives. solid phase: monoclonal mouse anti-CK-BB antibody(~0.06 mgg/mL) covalently coupled to paramagnetic particles in buffer with protein stabilizers, sodium azide (0.1%), and preservatives.(2) CKMB Calibrator: After reconstitution, low or high levels of CK-MB in equine serum with gentamicin sulfate, preservatives, and protein stabilizers.

• 關聯藥證數量: 1

(1) Enzyme Reagent (R1)12U/mL of glycerol-3-phosphate oxidase(GPO),0.22mg/mL of N-(2-hydroxy-3-sulfopropyl)-3,5-dimethoxyaniline sodium salt (HDAOS),1.5U/mL of glycerol kinase (GK), 1.5mg/mL of adenosine-5’-triphosphate (ATP-2Na)(2) Enzyme Reagent B (R2)1400 U/mL of lipoprotein lipase (LPL),4.1mg/mL of 4-aminoantipyrine

• 關聯藥證數量: 1

(1) Enzyme\n0.1 mol/L Good’s buffer, pH 6.5 \ncontaining\n0.9 IU/mL hexokinase\n4 IU/mL glucose-6-phosphate dehydrogenase\n0.8 mmol/L β-nicotinamide adenine dinucleotide oxidized form\n(2) ATP Solution\n0.25 mol/L Tris buffer, pH 10.5 \ncontaining\n5.5 mmol/L adenosine 5’-triphosphate (ATP)\n

• 關聯藥證數量: 1

(1) Reagents\n1. Antibody Reagent\nAntibody monospecific for fibrinogen is supplied.\n2. Antibody Diluent: Polymer Diluent III\n60 mL of a polymeric enhancer solution is supplied.\n3. Sample Diluent: Diluent A\n50 mL Diluent A is supplied.\nContains 0.1% Sodium Azide.\n(2) Calibration Standard for Fibrinogen\nVial of Standard contains lyophilized pooled human plasma.\n(3) Control for Fibrinogen\nEach vial of Control contains lyophilized pooled human plasma.\n

• 關聯藥證數量: 1

(1) 12 microtiter strips (in 1 strip holder) (code VZV M)\n(2) 2.5ml VZV IgM negative control (green cap)\n(3) 2.5ml VZV IgM positive control (red cap)\n(4) 100 ml dilution buffer IgM (blue cap)\n(5) 12 ml Anti-IgM conjugate (white cap)\n(6) 50 ml washing solution (white cap)\n(7) 15 ml substrate reagent (black cap)\n(8) 15 ml stop solution (red cap)

• 關聯藥證數量: 1

(1) ACS: 180 DPD: lite reagent, solid phase\nlite reagent: monoclonal mouse anti-DPD antibody (~450 ng/vial) and polyclonal goat anti-mouse antibody (~195 ng/vial) labeled with acridinium ester in buffered saline with sodium azide (<0.1%) and preservatives.\nsolid phase: pyridinoline (~0.6 ug/vial) conjucated to avidin (~20 ug/vial) coupled to paramagnetic particels in buffered saline with sodium azide(<0.1%) and preservatives.\n(2) DPD 1,2,3 quality control material: after reconstitutuion, various levels of deoxypyridinoline in buffer with sodium chloride and preservatives.\n(3) DPD Calibrator: after reconstitution, low or high levels of deoxypyridinoline in buffer with sodium chloride and preservatives.

• 關聯藥證數量: 1

(1) ADVIA Centaur CA 125II:\n lite reagent: monoclonal mouse anti-M11 antibody labeled with acridinium ester and monoclonal mouse anti-OC 125 labeled with fluorescein in phosphate buffer with bovine serum albumin and preservatives \nsolid phase: monoclonal mouse anti-fluorescein antibody coupled to paramagnetic particles in phosphate buffer with bovine serum albumin and preservatives\n(2) CA 125II Calibrator: low or high level of CA125 in buffered human serum albumin with sodium azide and preservatives.

• 關聯藥證數量: 1

(1) ADVIA Centaur CA 15-3: lite reagent, solid phase, conjugate reagent.\n(2) CA 15-3 Calibrator: after reconstitution, low or high level of CA 15-3.

• 關聯藥證數量: 1

(1) ADVIA Centaur CEA: lite reagent, solid phase\n(2) ACS: 180 CEA: lite reagent, solid phase\nlite reagent: polyclonal rabbit anti-CEA antibody labeled with acridinium ester in phosphate buffered saline.\nsolid phase: monoclonal mouse anti-CEA antibody (~120 ug/mL) covalently coupled to paratmagnetic particles in phosphat buffered saline.

• 關聯藥證數量: 1

(1) ADVIA Centaur Cortisol: lite reagent, solid phase.\n(2) ACS: 180 Cortisol: lite reagent, solid pahse.\nlite reagent: cortisol (~1.7 ng/ml) labeled with acridinium ester in buffered saline with sodium salicylate (~50 mg/mL), sodium azide (0.1%) and preservatives.\nsolid phase: rabbit anti-cortisol antibody (~1.1 ug/mL) bound to monoclonal mouse anti-rabbit IgG antibody (~56 ug/mL) covalently coupled to paramagnetic particles in buffered saline with sodium azide (0.1%) and preservatives.

• 關聯藥證數量: 1

(1) ADVIA Centaur FOL: lite reagent, solid phase, binding protein, low calibrator, high calibrator(2) ADVIA Centaur FOL DTT/Releasing Agent: DTT, releasing agent(3) ACS: 180 aTG: lite reagent, solid phase, binding protein, DTT, releasing agent, low calibrator, high calibratorlite reagent: folate labeled with acridinium ester(~9.8 ng/mL) in buffer bovine serum albumin, sodium azide(0.1%), and preservativessolid phase: purified avidin (~20 ug/mL) covalently coupled to paramagnetic particles in buffer with human serum albumin and preservativesbinding protein: purified folate binding protein (~1.0 ug/mL) covalently coupled to biotin in buffer with bovine serum albumin and preservativesDTT: dithiothreitol (~95 mg/mL) in liquid formReleasing agent: sodium hydroxideCalibrators: after reconstitution, low or high levels of N-5-methyl-tetrahydrofolic acid in buffer with human serum albumin with sodium azide (<0.1%) and preservatives

• 關聯藥證數量: 1

(1) ADVIA Centaur FT3 : lite reagent, solid phase \n(2) ACS : 180 FT3 : lite reagent, solid phase \n lite reagent : monoclonal mouse anti-T3 antibodies (~8ng/mL) labeled with acridinium ester in HEPES buffer with protein stabilizer and sodium azide (0.1%)\n solid phase : T3 analog (~1.6 ug/mL) covalently coupled to paramagnetic particles in HEPES buffer with sodium azide (0.1%)\n

• 關聯藥證數量: 1

(1) ADVIA Centaur Insulin: lite reagent, solid phase. (2) ACS: 180 Insulin: liter reagent, solid phase.lite reagent: monoclonal mouse anti-insulin antibody labeled with acridinium ester in buffered saline with bovine serum albumin.solid phase: monoclonal mouse anti-insulin antibody covalently coupled to paramagnetic particles in buffered saline with bovine serum albumin.(3) IRI Calibrator: low or high levels of insulin in buffered saline with casein, potassium thiocyanate (3.89%).

• 關聯藥證數量: 1

(1) ADVIA Centaur T4: lite reagent, solid phase\n(2) ACS: 180 T4: lite reagent, solid phase, T3/T4 releasing agent\nlite reagent: monoclonal mouse anti-T3 antibody (~1 ug/mL) labeled with acridinium ester in sodium barbital buffer with protein stabilizers, ANS, EDTA, and sodium azide (0.1%)\nsolid phate: T4(~0.2 ug/mL) covalently coupled to paramagnetic particles in sodium barbital buffer with protein stabilizers, ANS, EDTA, and sodium azide (0.1%)\nT3/T4 releasing agent: 0.4 N sodium hydroxide

• 關聯藥證數量: 1

(1) ADVIA Centaur TSH-3: lite reagent, solid phase, low calibrator, high calibrator\n(2) ACS: 180 TSH-3: lite reagent, solid phase, low calibrator, high calibrator\nlite reagent: monoclonal mouse anti-TSH antibody (0.3 ug/mL)labeled with acridinium ester in HEPES buffered saline.\nsolid phase: polyclonal sheep anti-TSH antibody (53 ug/mL) covalently coupled to paramagnetic particles in HEPES buffered saline.\ncalibrators: after reconstitution, low and high levels of TSH in HEPES buffered equine serum.\n(3) master curve material: various levels of thyroid-stimulating hormone in lyophilized equine serum.

• 關聯藥證數量: 1

(1) ADVIA Centaur VB12: lite reagent, solid phase(2) ADVIA Centaur VB12 DTT/Releasing Agent(3) ACS:180 VB12: lite reagent, solid phase, releasing agent, DTTlite reagent: acridinium ester-labeled vitamin B12(~3 ng/mL) in buffered with sodium azide (0.1%), protein stabilizers, and preservativessolid phase: purified hog intrinsic factor (~0.025ug.mL) covalently coupled to paramagnetic particles in buffered with sodium azide (0.1%), protein stabilizers, cobinamide, and preservativesreleasing agent: sodium hydroxide (~0.30 N) with potassium cyanide (~0.05mg/mL)DTT: dithiothreitol(~105mg/mL)

• 關聯藥證數量: 1

(1) ADVIA Centaur aTG: lite reagent: human thyroglobulin (~0.38 ug/mL) labeled with acridinium ester in buffer with BSA, sodium azide (<0.1%), protein stabilizers, and preservatives.solid phase: polyclonal human anti-Tg antibody (~1.98 ug/mL) bound to polyclonal goat anti-human antibody (~49.5 ug/mL) covalently coupled to paramagnetic particles in buffer with BSA, sodium azide (<0.1%) and preservatives.(2) aTG, 1,2, quality control material (3 vials for each level, 2 mL/vial): various levels of anti-Tg in human plasma with sodium azide (<0.1%) and preservatives.(3) Calibrator 1 (2 vials for each level, 1 mL/vial): low or high levels of anti-Tg in human plasma with sodium azide (<0.1%) and preservative

• 關聯藥證數量: 1

(1) ADVIA Centaur cTnI: lite reagent, solid phase, low calibrator U, high calibrator U(2) ACS:180 cTnI: lite reagent, solid phase, low calibrator U, high calibrator Ulite reagent: polyclonal goat anti-cTnI antibody labeled with acridinium ester in tris buffer with protein stabilizers and preservativessolid phase: monoclonal mouse anti-cTnI antibodies covalently coupled to paramagnetic particles in tris buffer with protein stabilizers and preservativescalibrators: after reconstitution, low or high levels of cardiac troponin I and myoglobin in goat serum with preservatives and stabilizers

• 關聯藥證數量: 1

(1) ADVIA Centaur iPTH: lite reagent, solid phase. \n(2) ACS: 180 iPTH: lite reagent, solid phase. \nlite reagent: biotinylated polyclonal goat anti-human PTH (39-84 region) antibody (~8 ug/mL) and acridinium ester-labeled polyclonal goat anti-human PTH (1-34 N-terminal) antibody (~1 ug/mL). \nsolid phase: streptavidin (~0.4 mg/mL) covalently coupled to paramagnetic latex particles in phosphate buffered saline with goat IgG, bovine gamma globulin.\n(3) iPTH 1,2,3,quality control material: 1 mL/vial after reconstitution, various levels of intact PTH in phosphate buffered saline with equine serum. \n(4) iPTH Calibrator: 1 mL/vial after reconstitution, low or high levels of intact PTH.

• 關聯藥證數量: 1

(1) ADVIA Centaur tIgE: lite reagent, solid pahse.\n(2) ACS: 180 IgE: lite reagent, solid phase.\nlite reagent: goat anti-human IgE antibody (~2.4 ug/mL) labeled with acridinium ester.\nsolid phase: mouse anti-human IgE antibody (~0.02 mg/mL) covalently coupled to paramagnetic particles.\n

• 關聯藥證數量: 1

(1) Alkaline\n 0.10 mol/L sodium tetraborate containing sodium hydroxide\n(2) Additional A\n 0.20 mol/L periodic acid\n(3) Picric Acid\n 8.7 mmol/L 2,4,6-trinitrophenol (picric acid)\n(4) Additional B\n containing diethanolamine\nCreatinine Standard Solution contains creatinine and stabilizer.\n

• 關聯藥證數量: 1

(1) Buffer\n 50 mmol/L Good’s buffer (pH 7.4)\n(2) RF Reagent\n Heat-aggregated human IgG (1mL/mL) \n(3) RF TIA Calibrator 1, 2, 3, 4, 5\n Rheumatoid factor from human sera\n

• 關聯藥證數量: 1

(1) Buffer\n Good’s buffer, pH 8.2

• 關聯藥證數量: 1

(1) Enzygnost Anti-HSV/IgG Test Plate(2pcs): Microtitration plate coated with inactivated HSV Ag.\n(2) Anti-Human IgG/POD Conjugate(1 ×1mL): F(ab)’ fragment of rabbit Ab to human IgG, conjugated with peroxidase, in TRIS/HCl buffer with polygeline and dye(patent blue, tartrazine), preservative(phenol≦1g/L).\n(3) Conjugate Buffer Microbiol (4 ×12.5mL): EDTA in phosphate buffer with Tetronic and BSA and preservatives (gentamicin: ~100 mg/L, 5-chloro-2-methyl-isothiazole-3-one: ~6mg/L, 2-methyl-4-isothiazole-3-one: ~2mg/L). \n(4) Anti-HSV Reference P/N(1 ×0.4mL): human serum containing IgG Ab to HSV Ag in TRIS/HCl buffer with Humanalbin and preservatives (amphotericin B: ~5 mg/L, gentamicin:~100 mg/L).\n(5) Sample Buffer POD(2 ×50mL): TRIS/HCl buffer with Tween 20, polygeline and bovine serum and preservatives (amphotericin B: ~5 mg/L, gentamicin: ~100 mg/L).\n

• 關聯藥證數量: 1

(1) Enzyme Color A\n0.1 mol/L Goods buffer, pH 7.0\ncontaining\n2 U/mL peroxidase\n3.5 IU/mL ascorbate oxidase\n0.51 mmol/L N-(3-sulfopropyl)-3-methoxy-5-methylaniline\n(2) Enzyme Color B\n0.1 mol/L Goods buffer, pH 7.0\n0.88 IU/mL uricase\n4 mmol/L 4-aminoantioyrine

• 關聯藥證數量: 1

(1) Enzyme Color A\n0.2 mol/L Goods buffer, pH7.0 containing 2.1 U/mL peroxidase (Horseradish), 2.5 U/mL ascorbate oxidase (Acremonium sp.) and 0.36 mmol/L F-DAOS.

• 關聯藥證數量: 1

(1) Enzyme: 0.1M Good’s (BES) buffer, pH 7.7 Glucoamylase 16 IU/mL a-glucosidase 20 IU/mL (2) Substrate: 10 mM Good’s (BES) buffer, pH 5.0 BG5P 4.2 mmol/L

• 關聯藥證數量: 1

(1) Goat anti mouse IgG (22%)\n(2) Goat anti α-hCG (38%)\n(3) Mab anti β-hCG (40%)

• 關聯藥證數量: 1

(1) IMMUNOCHROMATOGRAPHIC TESTING DEVICE: 25PCS OR 50 PCS 1.DEVICE COATED MEMBRANE(7MM): COAT ANTI-MOUSE ANTIBODY FOR REFERENCE LINE 0.001G HCV ANTIGEN SOLUTION FOR TEST LINE 0.001G 2.FIBERGLASS(7MM): COLLOIDAL GOLD AU-AB/AG CONJUGATE SOLUTION FOR FIBERGLASS COATING 0.014G

• 關聯藥證數量: 1

(1) Latex solution 8mL 1 bottle\n Latex coated with Rabbit anti-IgE polyclonal antibody\n 8mL/bottle \n(2) Stabilizing solution 18mL 1 bottle \n \n

• 關聯藥證數量: 1

(1) OC-LIGHT: 1.PVA binding glass fiber, blue latex, bovine serum albumin, Tris (hydroxymethyl) aminomethane, sucrose, mouse anti-human IgG, rabbit anti-human IgG. 2.Nitrocellulose, mouse anti-human IgG, anti-mouse IgG rabbit IgG, sodium monophosphate, sodium diphosphate, sodium chloride.\n(2) Sampling bottle: HEPES, sodium hydroxide, sodium chloride, sodium azide, bovine serum albumin.\n

• 關聯藥證數量: 1

(1) Procleix Ultrio Plus Assay \nInternal Control Reagent、Target Capture Reagent、Target Enhancer Reagent、Amplification Reagent、 Enzyme Reagent、Probe Reagent、Selection Reagent、Negative Calibrator、HIV-1 Positive Calibrator、HCV Positive Calibrator、HBV Positive Calibrator \nReagents provided separately:\n(2) Procleix Ultrio Plus HIV-1, HCV and HBV Discriminatory Probe Reagents \nHIV-1 Discriminatory Probe Reagent、HCV Discriminatory Probe Reagent、HBV Discriminatory Probe Reagent \n(3) Procleix Assay Fluids\nWash Solution、Oil、Buffer for deactivation Fluids \n(4) Procleix AutoDetect Reagents\nAuto Detect 1、Auto Detect 2 \n(5) Procleix System Fluid Preservative \n(6) Procleix Ultrio Plus TIGRIS Controls\nProcleix Ultrio Plus TIGRIS Negative Control、Procleix Ultrio Plus TIGRIS HIV-1 Control、Procleix Ultrio Plus TIGRIS HCV Control、Procleix Ultrio Plus TIGRIS HBV Control

• 關聯藥證數量: 1

(1) Substrate-Enzyme 35 mmol/L Tris buffer, pH 9.0 (25°C) containing 100 mmol/L L-aspartate 0.031 mmol/L β-nicotinamide adenenine dinucleotide reduced from (NADH, form yeast) 2900 IU/L (37°C) malate dehydrogenase (MDH, from microorganism) 4000 IU/L (37°C) lactate dehydrogenase (LDH, from microorganism)(2) α-KG 178 mmol/L Tris buffer, pH 5.6 (25°C) containing 420 mmol/L L-aspartate 31 mmol/L α-ketoglutarate

• 關聯藥證數量: 1

(1) Test Cells: freeze-dried equivalent of 3 ml of 1% suspension of aldehyde treated, tanned turkey erythrocytes coated with human thyroglobulin dispersed in phosphate buffered saline pH 7.2, containing 5% sucrose, 1.5% normal rabbit serum and 0.01% Bronopol.\n(2) Control Cells: freeze-dried equivalent of 3 ml of a 1% suspension of aldehyde treated, tanned turkey erythrocytes dispersed in phosphate buffered saline pH 7.2, containing 5% sucrose, 1.5% normal rabbit serum and 0.01% Bronopol.\n(3) Diluent: 25 ml of isotonic saline containing normal human serum negative for HBsAg and antibodies to HIV-1 and HIV-2 and HCV, normal turkey serum, human thyroglobulin and 0.1% sodium azide.\n(4) Positive Control Serum: 1.0 ml of sheep anti-thyroglobulin serum having a haemagglutinating titre of approximately 1/640 with Test Cells. The serum contains 0.1% sodium azide.\n(5) Negative Control Serum: 1.0 ml of normal human serum negative for HBsAg and antibodies to HIV-1 and HIV-2 and HCV. The serum contains 0.1% sodium azi

• 關聯藥證數量: 1

(1) Test Cells: freeze-dried equivalent of 3 ml of 1% suspension of aldehyde treated, tanned turkey erythrocytes coated with microsomal antigen dispersed in phosphate buffered saline pH 7.2, containing 5% sucrose, 1.5% normal rabbit serum and 0.01% Bronopol.\n(2) Control Cells: freeze-dried equivalent of 3 ml of a 1% suspension of aldehyde treated, tanned turkey erythrocytes dispersed in phosphate buffered saline pH 7.2, containing 5% sucrose, 1.5% normal rabbit serum and 0.01% Bronopol.\n(3) Diluent: 25 ml of isotonic saline containing normal human serum negative for HBsAg and antibodies to HIV-1 and HIV-2 and HCV, normal turkey serum, human thyroglobulin and 0.1% sodium azide.\n(4) Positive Control Serum: 1.0 ml of diluted rabbit anti-microsomal serum. Contains 0.1% sodium azide.\n(5) Negative Control Serum: 1.0 ml of diluted normal human serum negative for HBsAg and antibodies to HIV-1 and HIV-2 and HCV. Contains 0.1% sodium azide.\n\n

• 關聯藥證數量: 1

(1).IMMUNOCHROMATOGRAPHIC TESTING DEVICE : 1 PCS 1.DEVICE COATED MEMBRANE (7MM): COATING REFERENCE LINE SOLUTION 0.001G HIV 1/2 TEST LINE SOLUTION 0.001 2.FIBERGLASS (7MM): HIV1/2 COLLOIDAL GOLD CONJUGATE SOLUTION FOR FIBERGLASS COATING GP-41 0.014G HIVE1/2 COLLOIDAL GOLD CONJUGATE SOLUTION FOR FIBERGLASS COATING GP-36 0.014G

• 關聯藥證數量: 1

(1)ACS: 180 BR(#116272, #116271):\nlite reagent: monoclonal mouse anti-CA 15-3 antibody (~3 ug/vial) labeled with acridinium ester in buffered saline with preservatives.\nsolid phase: human CA 15-3 (~9 U/vial) covalently coupled to paramagnetic particels in buffere with preservatives.\npretreatment reagent: sodium hydroxide (0.55 N).\n(2)Calibrator G(#672186, #672185): after reconstitution, low or high levels of CA 15-3 in equine serum with sodium azide (0.1%) and preservatives.

• 關聯藥證數量: 1

(1)ACS： OV：\n lite reagent：monoclonal mouse antibody to CA 125 (~ 6 ug/vial) labeled with acridinium ester in phosphate buffer with protein stabilizers, sodium azide (<0.1%), and preservatives\n solid phase：monoclonal mouse antibody to CA 125 (~ 0.55 mg/vial) coupled to paramagnetic particles in in phosphate buffer with protein stabilizers, sodium azide (<0.1%), and presrvatives\n(2)Calibrator X：after reconstitution, low or high levels of CA 125 in buffered human serum albumin with sodium azide (<0.1%) and preservatives

• 關聯藥證數量: 1

(1)ADVIA Centaur CpS：lite reagent,solid phase\n(2)ACS：180 CpS：lite reagent,solid phase \nlite reagent：monoclonal mouse anti-C-peptide antibody(0.29 ug/mL)labeled with acridinium ester in phosphate buffer with bovine serum albumin,sodium azide (<0.1%),and preservatives\nsolid phase：monoclonal mouse anti-C-peptide antibody(~2.3 ug/mL)covalently coupled to paramagnetic particles in phosphate buffer with bovine serum albumin,sodium azide(<0.1%),and preservatives\n

• 關聯藥證數量: 1

(1)ADVIA Centaur FER：lite reagent,solid phase\n(2)ACS：180 FER：lite reagent,solid phase\nlite reagent：polyclonal goat anti-ferritin antibody labeled with acridinium ester in HEPET buffer\nsolid phase：monoclonal mouse anti-ferritin antibody covalently coupled to paramagnetic particles in sodium barbital buffer

• 關聯藥證數量: 1

(1)Albumin Antiserum（HAD1）：22 mL of anti-human albumin antiserum supplied in liquid form.\n(2)125I Albumin (HAD2）：Lyophilized iodinated human serum albumin.\n(3) Albumin Calibrators(HAD3 8）：labed A through F, of lyophilized calibrators.

• 關聯藥證數量: 1

(1)Albumin: bis(3,3-diiodo-4,4-dihydroxy-5,5-dinitrop henyl)-3,4,5,6-tetrabromosulfonephthalein 1.9%.\n(2)Creatinine: copper sulfate 2.5%;\ndiisopropylbenzene dihydroperoxide 4.5%;\n3,3,5,5-tetramethylbenzidine 2.0%

• 關聯藥證數量: 1

(1)Alkaline Reagent.(2)Surfactant.(3)Color Reagent6.87 mg/mL of 2,4,6-trinitrophenol.

• 關聯藥證數量: 1

(1)BUFFER (R1) 23.96MG/ML OF GLYCYLGLYCINE(2)SUBSTRATE REAGENT (R2) 7.5MG/ML OF r-GLUTAMYL-3-CARBOXY-P-NITROANILIDE

• 關聯藥證數量: 1

(1)Buffer (R1)

• 關聯藥證數量: 1

(1)Coenzyme\n Tris buffer (pH 9.5) containing：β-nicotinamide adenine dinucleotide, reduced from (NADH, from Yeast)\n(2)Substrate-Enzyme\n Phosphate buffer (pH 6.6) containing：urease (from Jack Bean) glutamate dehydrogenase (GIDH, Bovine liver) α-ketoglutarate (α-KG)

• 關聯藥證數量: 1

(1)Dry material: Freeze dried bovine albumin. \n(2)Dissolution liquid: Solution of Na,K,CL and others in water.

• 關聯藥證數量: 1

(1)Enzyme Reagent A (R1) 2.511 mg/mL of β-nicotinamide adenine dinucleotide phosphate oxidation type(NADP) \n(2)Enzyme Reagent B (R2) 11U/mL of hexokinase (HK)\n

• 關聯藥證數量: 1

(1)Free T3 Bead Pack: \ncoated with monoclonal murine anti-T3. \n(2)Free T3 Reagent Wedge:\nligand-labeled T3 analog in buffer. 11.5 mL alkaline phosphatase (bovine calf intestine)conjugated to anti-ligand in buffer.\n(3)Free T3 Adjustors: \n2 vials (Low and High), of lyophilized free T3 in processed human serum.

• 關聯藥證數量: 1

(1)Immunochromatographic testing device:1pcs, 25pcs or 50pcs 1.Device coated Membrane (7mm):Coating reference line solution 0.001g HIV1/2 test line solution 0.001g 2.Fiberglass (7mm):HIV1/2 Colloidal gold conjugate solution for fiberglass coating gp-41 0.014g, HIV1/2 Colloidal gold conjugate solution for fiberglass coating gp-36 0.014g

• 關聯藥證數量: 1

(1)SD BIOLINE Influenza Antigen Test Strips are immobilized with mouse monoclonal anti-influenza A and anti-influenza B antibodies respectively.(2)Diluents.(3)control Swabs: Influenza A positive Control Swab.Influenza B positive control Swab.Influenza Negative Control Swab.

• 關聯藥證數量: 1

(1)Solid Phase 20.0 ml containing Streptavidin-coated paramagnetic microparticles preformed with biotinylated HIV antigens (~1.0μg/mL) in buffer with bovine serum albumin, goat serum, surfactant, and preservatives.\n(2)Lite Reagent 10.0 ml containing recombinant HIV antigens, labeled with acridinium ester in buffer with bovine serum albumin, mouse lgG, goat serum, surfactant, and preservatives.\n(3)Ancillary Lite Reagent 10.0 ml containing recombinant HIV antigens labeled with acridinium ester in buffer with bovine serum albumin, mouse lgG, goat serum, surfactant, and preservatives.\n(4)EHIV calibrator vials: 2.0 ml/vial processed human plasma negative for antibodies toHIV spiked with antibodies to HIV-1, sodium azide (<0.1%) and preservatives.\n\nEHIV quality control material containing 7.0 ml/vial processed human plasma nonreactive for HIV, reactive for HIV-1, and reactive for HIV-2 with preservatives.

• 關聯藥證數量: 1

(1)Standard and A-F (0.25, 1.0, 2.5, 10, 25, 50, 100 pg/ml). \n(2)free testosterone I-125 reagent (22ml, <5μCi of [I-125]-labeled testosterone.\n(3)free testosterone Controls (Low and High con.c of testerone in human serum).\n(4)free testosterone Ab-coated tubes (with rabbit antitestosterone immunoglobulin)

• 關聯藥證數量: 1

(2) Antibody\n Anti-human C4 antibody (goat polyclonal antibody)

• 關聯藥證數量: 1

(2) Enzyme Color B\n0.1 mol/L Goods buffer, pH7.0 containing 0.54 IU/mL uricase (Arthrobacter sp.), 2.7 mmol/L 4-aminoantipyrine (4AA) and 0.005% sodium azide.

• 關聯藥證數量: 1

(2) TESTING BUFFER:1 BOTTLE OR 2 BOTTLES HCV BOVINE SERUM BASE: BOVINE SERUM;AMMONIUM SULFATE 200G/L;0.85%SODIUM CHLORIDE;0.05M BORIC ACID;GENTAMICIN SULFATE 0.02G/L;PROCLIN 300 5ML/L

• 關聯藥證數量: 1

(2).TESTING BUFFER: 1 BOTTLE;SODIUM CHLORIDE 8.5G/L TWEEN-20 5ML/L;SODIUM AZIDE 0.2G/L;TRIZMA BASE(TRIS) 48G/L

• 關聯藥證數量: 1

(2)Antiserum Reagent (R2):\n0.15 mg/mL of anti-human CRP goat serum。

• 關聯藥證數量: 1

(2)Testing buffer : (0.5ml x 1, 10ml x 1or 10ml x 2)Sodium chloride 8.5g/L, Tween-20 5ml/L, Sodium azide 0.2g/L, Trizma base (Tris) 48g/L

• 關聯藥證數量: 1

(2,4-dichloro-benzen diazonium salt).....0.16 mg (0.40 umol)

• 關聯藥證數量: 1

(3) ADVIA Centaur Carbamazepine: lite reagent, solid reagent\n(4) ACS: 180 Catbamazepine: lite reagent, solid reagent\nlite reagent: carbamazepine derivative (~0.26 ng/mL) labeled with acridinium ester in buffer saline with sodium azide (<0.1%) and preservatives\nsolid phase: monoclonal mouse anti-carbamazepine antibody (~15.25 ug/mL) covalently coupled to paramagnetic particles in buffered saline with sodium azide (<0.1%) and preservatives\n

• 關聯藥證數量: 1

(3)POSITIVE CONTROL DESCRIPTION:BUFFERED PROTEIN SOLUTION CONTAINING HUMAN HCV ANTIBODY WITH PRESERVATIVE

• 關聯藥證數量: 1

(4)NEGATIVE CONTROL DESCRIPTION:BUFFERED PROTEIN SOLUTION WITH PRESERVATIVE

• 關聯藥證數量: 1

(A.) RECONSTITUTING SOLUTION (Liquid) : \nThis reagent is used for reconstitution of lyophilized Sensitized Cells and Un sensitized Cells,and consists of a phosphate buffered saline solution containing Normal rabbit serum and Sodium Azide (0.1﹪).\n(B.) SERUM DILUENT (Liquid): \nThis reagent is used for dilution of test serum and reconstitution of Serodia-HAAbsorbent and consists of a phosphate buffered saline solution containing Normal rabbit testicular extract,cell components of sonicated Reiter T. Phagedenis, normal rabbit serum and Sodium Azide (0.1﹪).\n(C.) SENSITIZED CELLS (Lyophilized)\nFixed chicken erythrocytes sensitized with components of pathogenic\nTreponema Pallidum(Nichols Strain). Each vial must be rehydrated withthe prescribed quantity of Reconstituting Solution( to obtain 0.375% suspension) before utilization.\n(D.) UNSENSITIZED CELLS (Lyophilized)\nFixed chicken erythrocytes. The reagent of each vial must be rehydrated with the prescribed quantity of Reconstituting Solution ( to obtain 0.37

• 關聯藥證數量: 1

(A.) Reconstituting Solution (Liquid) : Use for reconstitution of Sensitized Particles and Unsensitized Particles. This reagent contains 0.06% (W/V) Sodium Azide per vial as preservative.\n(B.) Sample Diluent (Liquid) : Use for dilution of Specimens. This reagent contains 0.10% (W/V) Sodium Azide per vial as preservative. \n(C.) Sensitized Particles (Lyophilized) : Lyophilized preparation of gelatin particles coated with Treponema Pallidum. Reconstituted by adding prescribed quantity of Reconstituting Solution. The reconstituted solution contains 0.08% (W/V) Sodium Azide per vial as preservative.

• 關聯藥證數量: 1

(Accutrend Cholesterol)\nComponents per test: CHE 1.44 U; CHOD 0.12 U; POD 0.2 U, 3,3’5,5’-tetramethylbenzidine 8.5 μg; non-reactive components 1.4 mg.\n(Accutrend Control CH1)\nContents: Aqueous solution that includes chemical auxiliaries and extract of animal origin. The origin of the biological components is as follows:\nProtein/lipoprotein serum (bovine). \n

• 關聯藥證數量: 1

(Accutrend Triglycerides)\nComponents per test: CHE (Candida cylindracae) 0.15 U, GK\nPOD 0.63 U, ATP 12 μg, etc.\n(Accutrend Control TG1)\nTriolein 280 mg/dl

• 關聯藥證數量: 1

(COBAS INTEGRA Digitoxin reagent)R1: Antibody reagent in vial A and B (liquid). Anti-digitoxin monoclonal antibody (mouse) in bufferR2: Microparticle reagent in vial C (liquid). Conjugated digitoxin derivative microparticles in buffer6 calibrators Digitoxin conc. 0,7,5,15,30,45,65 ng/mL

• 關聯藥證數量: 1

(COBAS INTEGRA Digoxin)\nReagents-working solutions : \nR1 Antibody reagent in vial A and B (liquid).\n Anti-digoxin monoclonal antibody (mouse) in buffer with preservative. \nR2 Microparticle reagent in vial C (liquid).\n Conjugated digoxin derivative microparticles in buffer with preservative. \n

• 關聯藥證數量: 1

(Chloral Hydrate), (Ethylene Glycol, acetic acid 99-100%), (Purified water, Sodium iodide, Aluminium Sulfate, Propyleneglycol), (Ethanol, methanol), (wasser), (Ethylene Glycol, acetic acid 99-100%), (Ethanol, methanol), (Ethanol, methanol), (Ethanol, methanol, acetic acid, 99-100%)

• 關聯藥證數量: 1

(Components in 100 strips)Sample receiving layer ; Boric acid 42.6 mg, sodium hydroxide 18.7mgIndicator layer ; Bromocresol green 4.0mg

• 關聯藥證數量: 1

(D.) Unsensitized Particles (Lyophilized) : Lyophilized preparation of tanned gelatin particles. Reconstituted by adding prescribed quantity of Reconstituting Solution. The reconstituted solution contains 0.08% (W/V) Sodium Azide per vial as preservative. \n(E.) Positive Control (Liquid) : This control is prepared from rabbit serum containing antibodies to T. Pallidum. The control should show a titer of 1:320 (Final Dilution). This reagent contains 0.10% (W/V) Sodium Azide per vial as preservative.

• 關聯藥證數量: 1

(E.) POSITIVE CONTROL (Liquid) : \nThis control is prepared from rabbit serum containing T. Pallidum and Sodium Azide (0.1﹪). The control should show a titer of 1:320 (Final Dilution).\n(F.) SERODIA-HA ABSOBENT (Lyophilized)\nUse for absorption of test sera which showed agglutination with unsensitized Cells The reagent must be rehydrated with the prescribed quantity of SERUM DILUENT.

• 關聯藥證數量: 1

(Estradiol contains not less than 97% and not more than 103% of C18H24O2, calculated on the anhydrous basis.)

• 關聯藥證數量: 1

(INH0.2/INH1/C/RA5) ; (S5/S10/EM7.5/EM15) ; (LVX1/PAS4/EA10/EA15) ; (MXF1/OFX2/K6/K12) ; (INH1/RA1/C) ; (K6/S10/EM5/C) ; (INH1/RA1/C，K6/S10/EM5/C) ; (INH1/INH0.2/RA1/C) ; (OFX2/S10/EM5/C) ; (S2/S10/EM7.5/EM10) ; (INH1/INH0.2/RA1/C，S2/S10/EM7.5/EM10) ; (C/EA10/EA15/PAS10) ; (C/LVX2/OFX2/K6) ; (C/EA10/EA15/PAS10，C/LVX2/OFX2/K6) ; (C/INH0.2/RA1/EM7.5) ; (EM10/S2/K6/PAS10) ; (INH0.2/INH1/RA1/RA5) ; (C/S2/EM10/EM5) ; (C/INH0.2/RA1/INH1) ; (S2/S10/EM5/EM10) ; (C/K5/INH1/INH0.2) ; (C/RA1/EM5/EM10) ; (C/OFX2/S2/S10) ; (PAS2/EA5/OFX2/RBU0.5)；(EA10/K5/OFX2/PAS2)；(INH0.2/INH1/S2/S10)；(RA1/RA5/EM5/EM10)；(EM7.5/K6/S2/S10)；(K6/K12/CAP10/LVX1)；(EM10/S2/K6/PAS8)；(PAS8/EA10/LVX1/RA5)；(EM5/K5/S2/S10)；(INH1/INH0.2/RA1/OFX2)；(C/PAS8/OFX2/RBU0.5)；(C/PAS8/EA10/RBU0.5)；(K6/K12/CAP10/OFX2)；(OFX2/MXF1/C/C)；(RA1/EM5/INH5/S10)；(C/C/EM5/EM5)；(C/OFX2/MXF1/AN6)；(AN4/K6/CAP10/OFX2)；(C/S2/EM5/EM10)

• 關聯藥證數量: 1

(LPG1) : Each barcode-labeled unit contains one bead coated with polyclonal rabbit anti-progesterone. LPGA :Two wedges(7.5mL each) containing ligand-labeled synthetic progesterone. LPGB : One wedge(7.5 mL)alkaline phosphatase (bovine calf intestine)conjugated to antiligand in buffer. \n(LPGL, LPGH) : Two vials (Low and High), 3mL each, of progesterone in processed human serum. \n(LPGZ) : 25 mLof processed progesterone-free human serum. \n

• 關聯藥證數量: 1

(O2) contains not less than 99.0%(v/v) 本品所含氧氣Oxygen(O2)應在99.0%(v/v)以上。

• 關聯藥證數量: 1

(PLAQUE-FORMING UNITS) OF OKA/MERCK STRAIN OF VZV

• 關聯藥證數量: 1

(Reagent) R1 Antibody reagent in vial A and B (liquid) Anti-primidone sheep serum in buffer, pH7.5. R2=SR Tracer reagent in vial C (liquid). Fluorescein-labeled primidone derivative in buffer, pH6.5.

• 關聯藥證數量: 1

(Reagent) R1 BICIN 50 mmol/L, Colipase≧1 mmol/L,Calcium chloride 10 mmol/L, Na-deoxycholate pH 8.0 R1=SR Tartrate buffer 10 mmol/L,1,2-dilauryl-rac-glycero-3-glutaric acid-16-methyl-resorufin)ester 0.27 mmol/L,Taurodeoxycholate 8.8 mmol/L

• 關聯藥證數量: 1

(Reagent) R1 N-Methyl-D-glucamine 400 mmol/L Lithium lactate 61mmol/L R2=SR NAD 6.1mmol/L

• 關聯藥證數量: 1

(Reagent):\nM: Streptavidin-coated microparticles, 6.5 mL\nR1: Anti-troponin T-Ab~biotin, 10mL\nR2: Anti-troponin T-Ab~Ru(bpy)32+, 10mL\n(Calset):\nTN-T Cal1: 2 bottles, 1.0 mL each.\nTN-T Cal2: 2 bottles, 1.0 mL each.

• 關聯藥證數量: 1

(Reagent)M Streptavidin-coated microparticles 6.5mlR1 Anti-N-MID Osteocalcin-Ab~biotin 10 ml R2 Anti-N-MID Osteocalcin~Ab~Ru(bpy)32+ 10 ml (CalSet)OSTEOC Cal1:2 bottles, each for 1.0mL of calibrator 1OSTEOC Cal2:2 bottles, each for 1.0mL of calibrator 2Osteocalcin (synthetic peptide, human sequence) in two concentration ranges (approx. 0 ng/mL and approx.280ng/mL) in a human serum matrix.

• 關聯藥證數量: 1

(Reagent)M Streptavidin-coated microparticles 6.5mlR1 Anti-cortisol-Ab~biotin 9mlR2 Cortisol-peptide~Ru(bpy)32+ 9ml(CalSet)CORT Cal1:2 bottles, each for 1.0mL of calibrator 1 CORT Cal2:2 bottles, each for 1.0mL of calibrator 2Cortisol (synthetic) in two concentration ranges (approx. 12.5 nmol/L or 0.45μg/dL and approx.1000 nmol/L or 36μg/dL)in a human serum matrix.

• 關聯藥證數量: 1

(Reagent)M Streptavidin-coated microparticles (transparent cap), 1 bottle, 6.5 mL: Streptavidin-coated microparticles, 0.72 mg/mL; binding capacity: 470 ng biotin/mg microparticles; preservative.R1 Anti-digoxin-Ab~Ru(bpy)32+ (gray cap), 1 bottle, 10ml: Monoclonal anti-digoxin antibody (mouse) labeled with ruthenium complex 15 μg/L; monoclonal anti-digoxin antibody (mouse) 5mg/L, phosphate buffer 100 mmol/L, pH 7.0; preservative.R2 Digoxin-dervative~biotin (black cap), 1 bottle, 10ml: Biotinylated digoxigenin 1.06 ng/ml; biotin 15μg/L; phosphate buffer 100 mmol/L, pH 7.0 ; preservative.(CalSet)DIGO Cal1: 2 bottles, each for 1.5mL of calibrator 1DIGO Cal2: 2 bottles, each for 1.5mL of calibrator 2Digoxin in two concentration ranges (approx. 0.61 ng/mL or 0.78 nmol/L and approx. 3.61 ng/mL or 4.62 nmol/L) in a buffer/protein (bovine serum) matrix.

• 關聯藥證數量: 1

(Reagent)M Streptavidin-coated microparticles (transparent cap), 1 bottle, 6.5 ml:Streptavidin-coated microparticles, 0.72 mg/mL, binding capacity: 470 ng biotin/mg microparticles; preservative.R1 Anti-CK-MB-Ab~biotin(gray cap), 1 bottle, 10 ml: Biotinylated monoclonal anti-CK-MB antibody(mouse)1.2mg/L; phosphate buffer 100 mmol/L, pH 7.0; preservative.R2 Anti-CK-MB~Ab~Ru(bpy)32+(black cap),1 bottle, 10mL:Monoclonal anti-CK-MB antibody (mouse) labeled with ruthenium complex 1.2 mg/L; phosphate buffer 100 mmol/L, pH 7.0; preservative.(CalSet)CK-MB STAT Cal1:2 bottles, each for 1.0mL of calibrator 1CK-MB STAT Cal2:2 bottles, each for 1.0mL of calibrator 2CK-MB (human) in two concentration ranges (approx. 1.5ng/mL and approx.25ng/mL) in a human serum matrix.

• 關聯藥證數量: 1

(Reagent)M Streptavidin-coated microparticles 6.5 mlR1 Anti-PSA-Ab~biotin 10 mlR2 Anti-PSA~Ab~Ru(bpy)32+ 9 ml(CalSet)free PSA Cal1: 2 bottles, each for 1.0 mL of calibrator 1free PSA Cal2: 2 bottles, each for 1.0 mL of calibrator 2

• 關聯藥證數量: 1

(Reagent)M Streptavidin-coated microparticles (transparent cap), 1 bottle, 6.5mL：Streptavidin-coated microparticles, 0.72mg/mL； binding capacity：470 ng biotin/mg microparticles； preservative.R1 Anti-CK-MB-Ab~biotin (gray cap), 1 bottle, 10ml： Biotinylated monoclonal anti-CK-MB antibody (mouse) 1.2mg/L； Phosphate buffer 100 mmol/L, pH 7.0； preservative.R2 Anti-CK-MB~Ab~Ru(bpy)32+ (black cap), 1 bottle, 10ml： Monoclonal anti-CK-MB-antibody (mouse) labeled with ruthenium complex 1.2mg/L; phosphate buffer 100 mmol/L, pH 7.0； preservative.(CalSet)CK-MB Cal1：2 bottles, each for 1.0mL of calibrator 1CK-MB Cal2：2 bottles, each for 1.0mL of calibrator 2CK-MB (human) in two concentration ranges (approx. 1.5 ng/mL and 25 ng/mL) in a human serum matrix.

• 關聯藥證數量: 1

(Reagent)M Streptavidin-coated microparticles 6.5mlR1 Anti-cytokeratin 19-Ab~biotin 10mlR2 Anti-cytokeratin 19-Ab~Ru(bpy)32+ 10ml(CalSet)CYFRA Cal1：2 bottles, each for 1.0mL of calibrator 1CYFRA Cal2：2 bottles, each for 1.0mL of calibrator 2Cytokeratin (human, from cell line MCF-7) in two concentration ranges(approx. 0 ng/mL and approx. 50 ng/mL) in a human serum matrix.

• 關聯藥證數量: 1

(Reagent)PT1 Pretreatment reagent 1 4.0mlPT1 Pretreatment reagent 2 4.0mlM Streptavidin-coated microparticles 6.5mlR1 Folate binding protein~Ru(bpy)32+ 10mlR2 Folate~biotin 10ml(CalSet)FOL Cal1:2 bottles, each for 1.6mL of calibrator 1FOL Cal2:2 bottles, each for 1.6mL of calibrator 2Folate in two concentration ranges (approx. 1ng/mL or 2.27 nmol/L and approx.18ng/mL or 40.86 nmol/L) in a human serum albumin matrix, sodium azide <1%.

• 關聯藥證數量: 1

(Reagent)PT1 Pretreatment reagent 1 4.0mlPT1 Pretreatment reagent 2 4.0mlM Streptavidin-coated microparticles 6.5mlR1 Intrinsic factor~Ru(bpy)32+ 10mlR2 Vitamin B12~biotin 8.5ml(CalSet)B12 Cal1:2 bottles, each for 1.6mL of calibrator 1B12 Cal2:2 bottles, each for 1.6mL of calibrator 2Vitamin B12 in two concentration ranges (approx. 100pg/mL or 74pmol/L and approx.1500pg/mL or 1107 pmol/L) in a human serum matrix, sodium azide <1%, sodium cyanide<0.1%, and preservative.

• 關聯藥證數量: 1

(Reagent)R1 TRIS buffer with bovine serum albumin and immunoglobulins (mouse) in vial A and B (liquid).R2=SR Latex particles coated with anti-CRP (mouse) in vail C (liquid).

• 關聯藥證數量: 1

(Reagent)R1 Antibody reagent in vial A (liquid). Anti-secobarbital antibody (sheep polyclonal) in buffer, pH7.5, with stabilizer andpreservative.R2 Diluent in vial B (liquid). Buffer containing stabilizer and preservative.R3=SR Tracer reagent in vial C (liquid). Fluorescein-labeled secobarbital derivative in buffer, pH8.0, with stabilizer and preservative.

• 關聯藥證數量: 1

(Reagent)R1 CAPSO buffer: 5 mmol/l, pH 9.65; NADH≧0.23 mmol/l (yeast) R2 BICIN buffer: 1000 mmol/l, pH 7.6; urease≧7.2 U/ml (jack bean); dextran-linked GLDH≧0.90 U/ml (bovine liver); α-ketoglutarate ≧8.3 mmol/l

• 關聯藥證數量: 1